Bayer Presents FIDELIO-DKD Phase III Study Cardiovascular Subgroup Analysis of Patients With Chronic Kidney Disease and Type 2 Diabetes Late-breaking data presented at AHA 2020 Scientific Sessions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results